Sens. Pat Toomey (R-Penn.) and Amy Klobuchar (D-Minn.) have introduced legislation that would end the nationwide medical device tax.
The 2.3 percent medical device excise tax — a tax paid whenever a purchase is made — became active in 2013. In July 2018, the House voted to permanently repeal the tax, with 283 members of Congress voicing their support for revocation.
AdvaMed staunchly opposes the device tax, arguing that the tax should be repealed so the industry can “make the multi-year investments in R&D and infrastructure necessary to sustain the innovation ecosystem and take the next leap forward in patient care.”